Paratek Pharmaceuticals
PRTK
#9039
Rank
NZ$0.21 B
Marketcap
NZ$3.70
Share price
0.00%
Change (1 day)
6.89%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -NZ$72.95 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.16 Billion. In 2022 the company made an earning of -NZ$75.4 Million a decrease over its 2021 earnings that were of -NZ$68.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$72.95 Million-3.25%
2022 -NZ$75.4 Million10.5%
2021 -NZ$68.23 Million-46.16%
2020 -NZ$0.13 Billion-31.93%
2019 -NZ$0.19 Billion11.12%
2018 -NZ$0.17 Billion21.19%
2017 -NZ$0.14 Billion-23.22%
2016 -NZ$0.19 Billion54.68%
2015 -NZ$0.12 Billion309.5%
2014 -NZ$28.43 Million-29.88%
2013 -NZ$40.55 Million
2011 -NZ$6.26 Million-59.18%
2010 -NZ$15.32 Million-53.53%
2009 -NZ$32.97 Million-161.93%
2008 NZ$53.22 M-187.43%
2007 -NZ$60.88 Million11.93%
2006 -NZ$54.39 Million31.69%
2005 -NZ$41.3 Million32.4%
2004 -NZ$31.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-NZ$0.87 Billion 1,086.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$34.32 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA